ASAHI YUKIZAI CORPORATION FY2026 FY Earnings Report

Financial Highlights

• Net Sales: ¥80.08B
• Operating Income: ¥7.58B
• Net Income: ¥3.29B
• EPS: ¥177.05

Income Statement

Balance Sheet

Cash Flow Statement

Profitability Ratios

Year-over-Year Comparison

Share Information

Dividend Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

FY2026 results show a clear earnings slowdown with resilient cash generation: topline softened while margins compressed, and one-time losses weighed on bottom line, but liquidity and leverage remained very strong. Revenue declined 6.0% YoY to 800.8, with operating income down 31.8% to 75.8 and net income to owners down 56.4% to 33.3. Gross profit was 295.2, translating to a gross margin of 36.9% versus 38.7% last year (down ~180 bps). Operating margin contracted to 9.5% from 13.1% (down ~360 bps) on weaker volume/pricing in Valve & Piping and Resin. Net margin fell to 4.2% from 9.0% (down ~480 bps) largely due to extraordinary losses (impairment 19.8 and asset disposals). Ordinary income of 79.6 exceeded operating income, supported by higher interest and dividend income, but extraordinary loss of 21.9 reduced EBT to 58.3. Cash flow quality was strong: operating cash flow was 104.5 (3.14x net income), reflecting working capital release in receivables and non-cash impairment. Free cash flow was positive at 9.1 after elevated capex of 86.6, resulting in a modest cash decrease of 8.3. The balance sheet strengthened further: equity rose to 815.9, interest-bearing debt stayed low at 64.9, and cash remained high at 232.3; current ratio stood at 380% and D/E at 0.33x. Segment-wise, Valve & Piping Systems remained the profit engine (62.9 OI, 13.0% margin), while Resin (4.0% margin) and Water Treatment (6.4% margin) were softer. Inventory intensity increased (DIO 155 days), elongating the cash conversion cycle to 165 days and suppressing operating leverage. One-time items were material, amounting to 63% of net income, which depressed reported ROE to 4.1% despite solid EBITDA of 109.6 (13.7% margin). Under JGAAP, goodwill amortization was immaterial at 0.77 (0.7% of EBITDA), and goodwill levels are very conservative (Goodwill/Equity 0.8%). Management guides for a recovery in the next fiscal year (sales 900, OI 85, NI 61), implying double-digit growth and normalization of extraordinary losses. Key forward drivers are inventory normalization, utilization of new capacity under construction (CIP 64.1), and demand stabilization in core Valve & Piping end markets. Dividend was maintained at 120 yen DPS (payout ~71%), supported by a strong cash position though not fully covered by FCF in a high-capex year.

Profitability Analysis

ROE (4.1%) = Net Profit Margin (4.2%) × Asset Turnover (0.738x) × Financial Leverage (1.33x). The largest deterioration came from net profit margin, driven by operating margin compression (−360 bps YoY) and extraordinary losses (impairment 19.8). Asset turnover also declined (0.738x vs ~0.805x last year) on lower sales against a larger asset base, while leverage modestly decreased (1.33x vs ~1.35x). Margin pressure reflected weaker volume and pricing in Valve & Piping and Resin, and a higher fixed-cost burden amid soft demand. The non-recurring impairment in Valve & Piping and corporate reduced EBT and net income this year; this impact is one-time, while the underlying operating margin trend depends on inventory normalization and demand recovery. Cost discipline was mixed: SG&A was 219.4, effectively flat YoY against lower revenue, implying negative operating leverage. Going forward, restoring gross margin via mix, pricing, and throughput is the key lever; leverage is already conservative and unlikely to drive ROE.

Growth Assessment

Revenue declined 6.0% to 800.8 as all three segments softened, led by Valve & Piping (−8.3%) and Water Treatment (−8.6%), with Resin nearly flat (−0.3%). Operating income fell 31.8% to 75.8 on lower gross margin and negative operating leverage. EBITDA held at 109.6 (−1.9% YoY vs implied prior 111.7), cushioning the P&L given higher D&A (3.38). Extraordinary losses (21.9) drove the disproportionate decline in net income to 33.3. The guide for the next fiscal year targets sales 900 (+12.4%) and operating income 85 (+12.1%), indicating expected demand normalization and initial returns on recent capex. A successful inventory drawdown (DIO 155) and improved throughput from capacity under construction should support margin recovery. End-market exposure remains concentrated in Valve & Piping; geographic mix shows Japan and US softness with relative resilience in “Other” regions. Execution on capex-to-revenue conversion and working capital normalization will dictate whether double-digit growth is achievable.

Financial Health

Liquidity is very strong: current ratio 379.7% and quick ratio 256.6%, with cash of 232.3 covering short-term loans 8.3x. Solvency is conservative: D/E 0.33x, debt/capital 7.4%, and debt/EBITDA 0.59x; interest coverage is robust at ~100x (EBIT/interest). No warning on current ratio or D/E thresholds. Maturity profile shows a high short-term debt ratio at 43.1%, but the absolute level is small (28.0) and well covered by cash, limiting refinancing risk. There is no evident maturity mismatch given current assets of 661.5 vs current liabilities of 174.2. Off-balance sheet obligations were not indicated. Notable balance sheet rotations include higher investment securities, increased long-term loans, larger intangibles, and a sizable build in construction-in-progress, all consistent with an investment phase.

Notable B/S Changes

Investment Securities: +20.67 (+90.1%) - Higher marketable investments; adds OCI volatility but low balance sheet risk. Long-term Loans: +14.92 (+67.8%) - Increased term debt to support capex; leverage remains conservative. Intangible Assets: +6.91 (+28.8%) - Elevated software/other intangibles consistent with modernization investments. Construction in Progress (CIP): +39.67 (+162%) - Significant expansion pipeline; monitor ramp-up timing and ROI.

Cash Flow Quality

OCF was 104.5, 3.14x net income, signaling high earnings quality; drivers included receivables reduction (+33.1) and non-cash impairment (+19.8), partly offset by lower payables (−9.9). Cash conversion (OCF/EBITDA) was 0.95x, indicating solid cash realization from operating earnings. Capex was elevated at 86.6 (CapEx/Depreciation 2.56x), yielding positive but thin FCF of 9.1; this is consistent with a capacity and modernization investment phase. Working capital intensity remains high (CCC 165 days) with DIO at 155 days, tying up cash and dampening operating leverage. No signs of aggressive working capital management were apparent; receivables improved while inventory remained elevated, suggesting demand softness rather than timing manipulation.

Dividend Sustainability

Total DPS was 120 yen, equating to a payout ratio of ~71.4% on reported earnings. Total cash dividends paid were 21.8 versus FCF of 9.1 (FCF coverage 0.38x), implying reliance on the large cash balance to bridge the gap in a high-capex year. Balance sheet strength (net cash position and ample liquidity) supports the current dividend level near term, but sustained coverage will depend on capex normalization and earnings recovery. Management’s next-year guide (EPS 324.75, DPS 65) implies a materially lower prospective payout ratio and improved coverage if targets are met. Buybacks were negligible, so the total return ratio is effectively dividends-only.

Risk Assessment

Business risks include Demand softness in Valve & Piping Systems (−8.3% sales, −30.6% OI) reducing operating leverage, High inventory intensity (DIO 155 days) raising obsolescence risk and margin drag, Project execution risk tied to large construction-in-progress (CIP 64.1; 21.3% of PPE), Concentration risk: Valve & Piping Systems accounts for 60.1% of revenue.

Financial risks include Short-term debt ratio at 43.1% introduces refinancing cadence risk, albeit mitigated by cash 8.3x short-term loans, Elongated cash conversion cycle (165 days) constrains operating cash generation during downturns, Elevated capex (2.56x depreciation) increases near-term cash needs until returns materialize.

Key concerns include High one-time items (extraordinary loss 21.9; 63.4% of NI) depressed earnings and ROE; watch for recurrence, Effective tax burden of 43% (tax burden 0.57) pressured net income; evaluate drivers and potential normalization, Inventory normalization pace will determine margin recovery and cash release.

Investment Implications

Key takeaways include Core profitability compressed (OPM 9.5%, −360 bps YoY) amid revenue decline and negative operating leverage, Earnings quality strong on cash metrics (OCF/NI 3.14x; OCF/EBITDA 0.95x) despite weak reported NI, Balance sheet is robust (current ratio ~380%, D/E 0.33x), supporting dividend and capex program, Extraordinary losses (impairment) are the primary swing factor to NI; underlying EBITDA remains resilient, High inventory and long CCC are the main execution headwinds for FY2027 recovery.

Metrics to watch include Gross margin trajectory and operating margin recovery toward low-teens, Inventory days (targeting sub-120) and CCC reduction, Capex deployment vs. start-up milestones for CIP assets and resulting asset turnover, Segment mix and order trends in Valve & Piping Systems (pricing, utilization, export demand), Tax rate normalization and absence of further impairments.

Regarding relative positioning, Within Japanese specialty materials and fluid handling peers, Asahi Yukizai exhibits stronger balance sheet conservatism and solid cash conversion but currently lags on ROE and margin due to elevated inventories and one-time impairment. Low goodwill and limited M&A risk differentiate downside protection, while execution on inventory and new capacity is key for re-rating.